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Substrate mimicry in the active center of a mammalian a-amylase:
structural analysis of an enzyme–inhibitor complex
Coralie Bompard-Gilles1, Patrice Rousseau2, Pierre Rougé2 and 
Françoise Payan1* 
Background:  a-Amylases catalyze the hydrolysis of glycosidic linkages in starch
and other related polysaccharides. The a-amylase inhibitor (a-AI) from the bean
Phaseolus vulgaris belongs to a family of plant defence proteins and is a potent
inhibitor of mammalian a-amylases. The structure of pig pancreatic a-amylase
(PPA) in complex with both a carbohydrate inhibitor (acarbose) and a
proteinaceous inhibitor (Tendamistat) is known, but the catalytic mechanism is
poorly understood.
Results:  The crystal structure of pig pancreatic a-amylase complexed with a-AI
was refined to 1.85 Å resolution. It reveals that in complex with PPA, the inhibitor
has the typical dimer structure common to legume lectins. Two hairpin loops
extending out from the jellyroll fold of a monomer interact directly with the active
site region of the enzyme molecule, with the inhibitor molecule filling the whole
substrate-docking region of the PPA. The inhibitor makes substrate-mimetic
interactions with binding subsites of the enzyme and targets catalytic residues in
the active site. Binding of inhibitor induces structural changes at the active site
of the enzyme.
Conclusions:  The present analysis reveals that there are extensive interactions
between the inhibitor and residues that are highly conserved in the active site 
of a-amylases; a-AI1 inactivates PPA through elaborate blockage of substrate-
binding sites. It provides a basis to design peptide analogue inhibitors.
a-Amylase inhibition is of interest from several points of view, for example the
treatment of diabetes and for crop protection.
Introduction
a-Amylases (a-1,4-glucan-4-glucanohydrolases) are a group
of enzymes widely distributed in microorganisms, plants
and animal secretions. They catalyse the hydrolysis of the
a-(1,4) glycosidic linkages found in starch components,
glycogen and various oligosaccharides. Porcine, human,
mouse and rat pancreatic a-amylases have a high degree of
homology in their amino acid sequences [1].
The three dimensional molecular model of porcine pancre-
atic a-amylase (PPA) has been described in detail [2]. Sub-
sequently, its interactions with a carbohydrate inhibitor
(acarbose) were defined by the determination of the struc-
ture of the PPA–acarbose complex at 2.2Å resolution, which
showed a number of structural differences between the
unliganded and liganded enzyme [3]. Recently, the struc-
ture of PPA in complex with the microbial inhibitor Ten-
damistat (74 amino acid residues), which belongs to the
class of proteinaceous inhibitors from Streptomyces, has
been reported [4]. This study shows that a segment of the
inhibitor structure binds into the enzyme catalytic cleft, 
but a single one of the predicted catalytically competent
residues, Glu233, is targeted by the inhibitor. The structural
changes observed in the PPA–acarbose complex [3] were
not detected in the active site of the PPA–Tendamistat
complex structure. 
Further structural information is required to increase our
knowledge of PPA’s function. The mechanism of enzyme
inhibition by the widely occurring natural inhibitors is par-
ticularly unclear. 
A number of proteinaceous inhibitors of a-amylases have
been characterized in higher plants and microorganisms
[5]. The seeds of the common bean, Phaseolus vulgaris,
were shown to contain a family of plant defence proteins
comprising phytohaemagglutinin (PHA), arcelin (ARL)
and a-amylase inhibitor (a-AI) [6]. These three proteins
have different functions, protecting seeds from being
digested by mammals or infested by bruchid larvae that
burrow into them.
a-AI inhibits the a-amylase in the digestive tract of
mammals and coleoptera [7]. Recently, it was shown that
when a-AI is expressed in a transgenic pea plant it inhibits
the growth of certain bruchid larvae [8]. Two forms of the
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a-amylase inhibitor have been described, a-AI1 and a-AI2
[9,10], which differ both in primary sequence and in their
inhibitory activity towards bruchids. a-AI1 predominantly
occurs in common bean seeds. A comparison of the amino
acid sequences of lectins (PHA and Lathyrus ochrus
Isolectin I [LoLI]) from the vetch L. ochrus and lectin-like
proteins (ARL and a-AI1) from P. vulgaris shows that all
four sequences have a high degree of both identity and
homology. It is evident, however, that the loops involved
in the carbohydrate-binding sites of lectins are absent in
ARL and a-AI1 [11]. 
a-AI1 strongly inhibits PPA [7,12] (Kd =3.5 ×10–11M at
neutral pH), but the pro-form is inactive until it is prote-
olytically processed at Asn77 [13]. Post-translational modi-
fication produces the active inhibitor (I) formed by the
noncovalent association of two polypeptide chains (a and
b) of 77 and 146 amino acid residues, respectively. Our
preliminary structural analysis of the PPA–a-AI1 complex
shows that it consists of a dimer of the inhibitor (I2) and
two molecules of the enzyme (E2) in the crystal (total mol-
ecular weight 150kDa) [14].
We describe here the structure of the complex between
PPA and a-AI1 at 1.85Å resolution. It reveals that there 
are extensive interactions between the inhibitor and the
enzyme’s active-site region. The interactions between a-AI
and PPA directly mimic the protein–carbohydrate interac-
tions observed in the PPA–acarbose complex [3].
Results and discussion
Structure of phaseolus vulgaris a-amylase inhibitor.
The overall architecture of the bean-inhibitor corresponds
to a classical lectin fold (Fig. 1). The structure is devoid 
of a-helices and contains an abundance of antiparallel
b sheets. In the crystal, two monomers (molecular weight
22.5kDa) each consisting of a concave 12-stranded
antiparallel b sandwich fold are associated  by a twofold
symmetry axis to create an extended b sheet with the
enzyme combining sites at the two far ends of the dimer.
The b-sheet-type hydrogen bonds between mainchain
atoms of the strands adjacent to and related by the twofold
axis seen in the legume lectin dimer are conserved in 
the a-AI1 dimer. When comparing the tertiary structures
of LoLI [15] (226 residues) and a-AI1 (204 residues), 133
equivalent Ca atoms superimpose with a root mean
square (rms) coordinate deviation of ~0.5Å. Differences
between the structures are confined primarily to the loop
regions (Fig. 1) and appear to be related to the different
carbohydrate-binding specificities of the two proteins. It is
noteworthy that in the a-AI1 structure, two lectin car-
bohydrate-binding site loops (from residues 99–113 and
125–134; the numbering refers to the LoLI sequence [11])
are truncated. If present, these loops would overlap with 
a region of the enzyme structure (residues 145–157). A
third loop, L2, (residues Ala209 and Glu210 of the lectins
monosaccharide-binding site) is significantly longer in the
inhibitor structure. The extended loop of a-AI1 interacts
with the active site of PPA (Fig. 1); the lectin residue
Glu210 superimposes with a inhibitor-residue involved in
the enzyme–inhibitor interaction (Trp188, see hereafter).
As shown on Figure 1, the carbohydrate/metal-binding
site of lectins is located close to the enzyme-binding site.
The processing site (Asn77) required for the activation of
a-AI1 is located in the region where the carbohydrate-
binding site occurs (around the lectin residue, Asp80), but
in the present PPA–a-AI1 structure residues Gln75, Ala76
and Asn77 are not seen in the electron density.
This high-resolution study reveals three N-glycosylation
sites at Asn12, Asn65 and Asn140 of each a-AI1 monomer.
The two N-linked disaccharides on Asn12 and Asn65 
are well ordered in the crystal, but for the branched car-
bohydrate projecting out from Asn140 there is no well
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Figure 1
Stereoview of the a-carbon chain of the
monomer unit of a-AI1 (red) superimposed on
that of LoLI (blue) [15]. Metal ions and amino-
acid sidechains involved in the lectin
carbohydrate-binding site are coloured yellow,
residues that interact with the active site of
PPA are coloured green. Location of the three
N-glycosylation sites is shown (the GlcNAc
moieties are coloured purple).
defined electron density beyond the N-glycosyl linkage.
The branched carbohydrate linked to Asn65 protrudes in
the solvent, and is stabilized by the usual hydrogen bonds
and hydrophobic interactions.
The most striking feature of a-AI1 is a branched disaccha-
ride projecting out from Asn12. This residue is located on
the segment connecting the first strand (part of the typical
monomer–monomer interface of the legume lectin family)
and a strand of the concave facing sheet. The two b-(1,4)-
linked N-acetylglucosamine GlcNAc entities are found in
a solvent channel that links the dimer to the enzyme, and
adopt an extended conformation parallel to the surface of
the dimer. They make direct or water-mediated hydrogen
bonds with residues from the twofold related monomers
(residues 12, 13 and 24 from one monomer and residues
170, 173 and 174 from the related monomer). These inter-
actions make a significant contribution to the stability 
of the dimer assembly. Asn12 is not far from the inhibitor
active site. The b strands of the hairpin loop (14–25)
establish b-sheet-type hydrogen bonds with the main-
chain atoms of adjacent strands of the parallel hairpin loop
L1 (29–46), which in turn are hydrogen bonded to those of
the hairpin loop L2 (171–189); L1 and L2 form part of the
active site of the inhibitor (see below). The GlcNAc moi-
eties identified here are not directly involved in the
enzyme-inhibitor interaction, however.
Residues involved in a-AI1 binding to PPA
Contrary to earlier enzymological studies [16], the present
structural analysis reveals that a-AI is dimeric and interacts
with two pancreatic enzyme molecules (PPA). Kinetics mea-
surements of the inhibition of PPA by a-AI1 (P Rousseau
and P Rougé, unpublished data) support the idea that a-AI1
ab units are themselves organized as dimers as seen in the
crystal PPA–a-AI1 structure, and that the structure observed
here is therefore biologically relevant.
In the present structure, each a-AI1 monomer (I) binds 
at the active site of an enzyme-molecule (E) (Fig. 2). 
The major interactions with PPA occur directly within the
V-shaped depression of the active site, which also binds
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Figure 2
Structure of the PPA–a-AI1 complex 
(a) Overall structure of the PPA–a-AI1
complex. PPA is shown with a-helices in red
and b-strands in blue. Connecting loops are
shown in yellow; a-AI1 is coloured purple. 
(b) The chain-fold of the PPA–a-AI1 complex,
given as Ca-backbone model. One monomer
unit of a-AI1 in interaction with a molecule of
PPA is shown. The residue numbers of PPA
are followed by an ‘E’. Figure was generated
using TURBO-FRODO [32].
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the carbohydrate inhibitor acarbose [3]. The inhibitor
a-AI1 completely blocks one end of the enzyme cavity
(the reducing end of the acarbose-ligand [3] and prevents
the access to the other end through steric hindrance. The
loops from domains B and A of the enzyme structure
(notation according to Qian et al., [2]), which build the
walls of the V-shaped active-site cavity [3], make strong
interaction with the inhibitory site of a-AI1. 
The high-resolution studies of PPA complexed with the
inhibitor acarbose [3,17] revealed in detail the arrangement
of the protein residues related to six subsites of the active-
site cleft. In the PPA–a-AI complex, two facing hairpin
loops emerging from the b sheet fold, which consists of the
stretches 29–46(I) in L1 and 171–189(I) in L2, lie fully in
the active-site depression of PPA making extensive hydro-
gen-bonding, hydrophobic and water-bridged contacts with
the enzyme active-site residues involved in PPA–acarbose
interactions [3] (Fig. 3; Table 1). The conformation of the
two functional hairpin loops is stabilized by hydrogen bonds
occurring between mainchain atoms of the facing strands
from the two loops. The presumed presence of a calcium
ion (see hereafter) integrated into this structure, stitching
together the two hairpin loops L1 and L2, contributes to
the integrity of the inhibitor active site. Note this structural
element brings together two loop regions which deviate
widely from the corresponding loops of LoLI.
Regions located in the neighborhood of the enzyme active-
site depression are also involved in the interactions with the
inhibitor. An external convex segment from the domain B
(residues 142–154(E)) interacts with a concave region of the
inhibitor (Table 1). Similarly, a long loop corresponding to
residues 349–357(E) from the domain A, which protrudes in
to the solvent in close proximity to the flexible 303–309(E)
loop [3], also participates in the interaction. The total buried
surface area in the a-amylase inhibitor complex is about
3050Å2 (1461Å2 for PPA and 1588Å2 for the inhibitor), one
of the largest reported values for a protein complex [18].
There are 50 residues from PPA and 40 residues from a-AI1
involved in the enzyme-inhibitor interface.
Conformational changes in the enzyme 
Upon binding of a-AI1, the structural changes observed 
at the active site of the enzyme are very different from
those induced by the carbohydrate inhibitor acarbose [3].
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Figure 3
Residues involved in PPA–a-AI1 interactions.
(a) Interaction of the two hairpin loops of the
inhibitor with the substrate-binding cleft. The
molecular surface of PPA is shown (gold). The
deep polysaccharide binding cleft can be
seen passing across the midsection of the
enzyme. The mainchain of a-AI1 is
represented by a blue tube, the two hairpin
loops (L1 and L2) interacting directly with the
active site are coloured green. The tyrosine
sidechains (residues 37, 186 and 190),
important to the interaction are depicted in a
stick representation and PPA surfaces of the
targeted catalytic residues are coloured red.
The branches of the processed loop (R74;
S78) can be seen at the top of the inhibitor
model, on both sides of the green hairpin
loops. (Figure was produced using GRASP
[35].) (b) Detailed stereoview of a close up of
sidechains involved in the complex formation.
Shows the two hairpin loops (green and
purple) of the inhibitor which insert into the
active site of the enzyme, also shown (blue)
are the amino acid residues of PPA involved in
the interaction. The catalytically competent
residues of the enzyme, Glu233, Asp300 and
Asp197, are coloured red. In the immediate
environment of the enzyme catalytic residues,
the brown sphere represents the position of
the chloride ion, the blue sphere indicates the
water molecule W643, present in the free
enzyme structure.
The flexible loop (residues 304–310(E)) which forms the
surface edge of the substrate binding site was previously
shown to move in toward the saccharide, thus reducing the
cleft breadth. In contrast, when PPA is complexed with
a-AI1, the same loop moves out toward the solvent, pushed
away by the inhibiting entity which takes its place in the
tight-binding inhibition process. The loop rotates outwards
~132° around an axis lying between Ca303 and Ca309. 
It should be noted that the sidechain of catalytic residue
Asp300 which rotates ~60° around the Ca–Cb bond upon
acarbose binding, is found in the PPA–a-AI1 complex, in
the same conformation as the free enzyme. The described
conformational changes are accompanied by readjustment
of the surrounding regions: the loop region including
residues 351–359 (E) (domain A shows particularly large
movements), the maximal mainchain movement being 6Å
(for Asn350). The fragment including residues 141–153 (E)
from the domain B is also displaced, the maximal mainchain
movement being 2Å for Ala144. Displacement of the loops
in response to the inhibitor binding can be seen in Figure 4.
As Wilcox and Whitaker [19] pointed out, inactivation of
a-amylase by a-AI1 is slow; this may be caused by a
requirement for a conformational change. The present data
does indeed show large conformational changes in PPA
structure upon a-AI1 binding.
In their structural analysis of the PPA–Tendamistat complex
[4], the authors proposed a conformational change of a-
amylase which would involve regions 305–310 and 57–61.
Our studies ([2,3], this work and M Qian and FP, unpub-
lished results) confirm that the region 304–309 corresponds
to a moving loop able to adopt different conformations
according to the ligand structure; however, the fragment of
sequence 57–61 appears as a well defined region in the elec-
tron-density maps and it adopts the same conformation in
free and all known complexed PPA structures.
Analysis of the inhibition scheme
In the structure of the PPA–a-AI complex, there is an
extended protein–protein interface that might account 
for the large inhibition constant (Ki=3.5×10–11); a similar
feature was observed in the structure of PPA complexed
with the proteinaceous inhibitor Tendamistat [4]. This
extended protein–protein interaction by itself might
inhibit the enzyme by sterically blocking the active-site
cleft as observed in the structure of barley a-amylase 
in complex with the proteinaceous inhibitor Barley a-
amylase/subtilisin inhibitor (BASI) [20]. However, analysis
of the latter complex did not reveal any structural change
or intimate enzyme–inhibitor contacts at the catalytic
center. The active site of the plant a-amylase, complexed
with BASI, appears to remain in the right conformation 
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Table 1
Total contacts in the PPA–a-AI complex.
Amino acid residues* Hydrogen bonds between PPA and a-AI atoms†
Enzyme residues Inhibitor residues Direct hydrogen bonds Water-mediated hydrogen bonds‡
Trp58, Trp59, Trp62 Tyr190, Gln187, Tyr186 – –
His101 Tyr186 His101 Nε2↔Tyr186 OH –
Ile148, Glu149, Ser150 Met40, Ser78, Ala79, Glu101 Glu149 O↔Ser78 N Glu149 Oε1↔W44↔Asp117 Od2
Tyr151, Asn152, Asp153 Asn115, Asp117, Thr182 Tyr151 OH↔Asp38 Od1 Tyr151 N↔W758↔Ser78 O
Gln156 Tyr151 N↔W758↔Thr182 Og1 
Leu162, Val163, Gly164, Asp38, Phe105, Ala185
Leu165 Tyr186, Trp188 Val163 N↔W694↔W8↔Ala79 O
Asp197, Ala198, Lys200, Asp38, Ser39, Tyr186 Asp197 Od1↔Tyr186 OH
His201 Lys200 Nz↔Asp38 O
His201 Nε2↔Asp38 Od1
His201 Nε2↔Asp38 Od2
Glu233, Ile235, Leu237 Gln20, Asp21, Ser36, Tyr37 Glu233 Oε1↔Tyr37 OH Ile255↔W35↔Asp38 Od2




Asn298, Asp300, Arg303 Gln31, Tyr34, Asn35, Tyr37 Asn298 Nd2↔Tyr37 OH Gly304 O↔W2↔His73 Nε2
Gly304, His305, Gly308 His73, Tyr190 Asp300 O↔Tyr190 OH His305 Nd1↔W33↔Tyr34 O
Gly309, Ala310, Ser311 Asp300 Od2↔Ser189 Og Gly309 O↔W83↔Gln31 Nε2
Ile312, Glu352 Ser311 N↔Asn35 Od1 Gly309 O↔W9↔Asn35 Nd2
Ser311 Og↔Asn35 Od1 Gly309 O↔W13↔W110↔Gln31 Nε2
Glu352 Oε1↔His73 N
*Contacts considered between 2.5 and 4 Å. †Contacts considered between 2.5 and 3.3 Å. ‡W refers to water molecule.
to accept the ligands. In the mammalian complexes, in
contrast, sidechains of inhibitor residues bind into the
active-site cleft. They make strong interactions with the
presumed catalytic residues, the chloride ligand and the
surface edge of the catalytic depression formed by the
flexible loop identified in Qian et al. [2,3]. It is thus clear
that depending on the structure of the ligand, the moving
loop adopts different conformations and strongly takes
part in the ligand docking. This suggests that the motion
of the active-site region is important for enzyme function
and necessary to dock the various ligands. Therefore we
suggest that in the intricate interaction pattern, strong
contacts occurring within the active-site cleft are strictly
associated with the extended protein–protein interaction
in the mammalian enzyme inhibition. 
As shown in Table 1, most of the inhibitor residues which
form the binding segments of the complex are found in the
two hairpin loops L1 and L2. In the structural analysis of
the complex PPA–Tendamistat [4], it was observed that
the loop region 304–309 (corresponding to the flexible loop
characteristic of the mammalian a-amylases) binds residue
Tyr15 of Tendamistat and therefore the authors suggested
that position 15 in the proteinaceous inhibitors is important
for strong interaction with mammalian a-amylases. In the
present analysis, a substantial number of the residues from
loop L1 and residue Tyr190 from loop L2 are engaged in
interactions with the flexible loop. We therefore argue that
these inhibitor elements are important in recognition and
inhibition of mammalian a-amylases.
Comparison of the binding segments of PPA identified in
the PPA–a-AI and PPA–Tendamistat complexes shows that
the same main regions of PPA are involved in the tight con-
tacts. In the present structure, however, 14 more enzyme
residues are involved in the interaction, including in particu-
lar all the presumed catalytic residues (Asp197, Glu233,
Asp300 and the chloride ligand Asn298), which are involved
in hydrogen bonds with inhibitor residues (Tyr186, Tyr37
and Ser189). In the PPA–Tendamistat complex, a segment
containing the staggered sidechains of the triplet Trp18,
Arg19 and Tyr20 (typical for this class of inhibitors) binds
into the catalytic site. Arg19 points out from a bulky head
feature to form a salt bridge with Glu233, and Tyr20 is
hydrogen bonded to His201 Nε2; in the present PPA–a-AI1
complex two hairpin loops lie completely in the active site
and Tyr37, protruding from the extremity of L1, makes
strong hydrogen bonds with the same catalytic residue
Glu233 (and with the chloride ligand, Asn298) while the
flanking residue Asp38 is hydrogen bonded to His201 Nε2.
Another a-AI1 residue Tyr186 (I) sticks into the heart of the
catalytic site, forming hydrogen bonds with the catalytic
nucleophile Asp197 [21]. Asp300, the third residue of the
presumed catalytic triad (Asp197, Glu233 and Asp300) is
connected to Ser189(I) through its carboxyl oxygen and to
Tyr190(I) through its carbonyl oxygen. A major feature
observed in the PPA–Tendamistat complex is the bulky
head of Tedamistat, containing six amino acids, (Tyr18,
Arg19, Tyr20, Thr55, Gly59, Tyr60). It apparently forms
hydrophobic contacts with the elements, also involved 
in the PPA–acarbose interaction (Trp58, Trp59, Tyr62,
Tyr151, Leu162, Val163), lining the active-site depression
[3]. This feature is also involved in the structure of a-AI1
complexed to PPA; in this case the inhibitor residues 
are: Ala185, Tyr186, Gln187, Trp188, Tyr190, Asp38 and
Phe105 (Table 1). In this interaction, the sidechain of
Gln187(I) stacks against the indole ring of Trp59(E) and the
residues of the structural feature consisting of Tyr190,
Gln187 and Tyr186 (I) form hydrophobic interactions with
the aromatic residues Trp58, Trp59 and Tyr62 (E) (Fig. 5).
From the published drawings [4] it appears that in the
PPA–Tendamistat structure Trp18 is also parallel to the
plane of Trp59 (E) and according to the analysis it is
involved in hydrophobic interactions with the aromatic
residues Trp58, Trp59 and Tyr62 (E). Additional hydropho-
bic interactions occur between Arg19 of Tendamistat and
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Figure 4
A stereoview of the superimposition of the
a-carbon backbone traces of free and a-AI1
complexed PPA structures (see text). The
thick lines correspond to the structure of the
complexed enzyme.
loop 141-153   
loop 345-357   
loop 303-310   
loop 141-153   
loop 345-357   
loop 303-310   
Active site cleft Active site cleft
Val 163 of PPA; Tyr20 (Tendamistat) and Tyr151, Leu162,
His201, Ile235 (E). In the PPA–a-AI1 structure the corre-
sponding regions of PPA are principally involved in stacking
with the inhibitor residues Phe105, Trp188 Tyr186, Tyr37
and Asp38; the residues Tyr20 (Tendamistat) and Asp38 (a-
AI1) are apparently surrounded by the same PPA-residues
(Tyr151, Leu162, His201, Ile235). According to the above
observations, we propose that the triplet Trp18-Arg19-
Tyr20 in Tendamistat corresponds to the sequence Tyr186-
Gln187-Tyr190-Trp188-Tyr37-Asp38 in the bean inhibitor.
Structural analyses of the mammalian complexes clearly
indicate the important role of the aromatic residues lining
the active site of the enzyme in recognition and binding of
the ligand.
Protein-engineering studies [22] based on the structural
analysis of the PPA–Tendamistat complex and a modeled
structure of a-AI1, suggest that residues Trp188, Arg74 and
Tyr190 of a-AI1 closely match the tripeptide sequence that
forms the inhibitory region in the bacterial a-amylase
inhibitor. These experiments led to the conclusion that the
three residues constitute the active site of a-AI1. According
to our data, Arg74 cannot have the role of Arg19 (in Ten-
damistat) namely that of interacting with a catalytic residue.
In the present structure, the sidechain of Arg74 (in the area
where the processing occurs) is not seen in the electron
density and could hardly be modeled. In this region of 
the protein, there is no room for the sidechain of this
residue. In the absence of any structural information, we
are not able to speculate further on the total inactivation
resulting from the replacement of Arg74 by asparagine [22].
However, according to the well defined electron-density
map and the reasonable B factor values observed for
residues Arg74 and Ser78, the absence of Gln75, Ala76 and
Asn77 in the a-AI1 structure could result from the post-
translational processing of the a-AI precursor. This is con-
sistent with the fact that the surrounding residues Arg74
and Asn77 are susceptible to a proteolytic cleavage by a
trypsin-like and an asparaginyl-endopeptidases enzymes
respectively. A similar excision process was shown to occur
during the post-translational maturation of the pea (Pisum
sativum, PsA) lectin precursor to give the two-chain (b+a)
lectin [23]. An excision event such as this might explain
why a single mutation occurring at Arg74 would result in
total inactivation of the a-AI inhibitor by preventing the
natural proteolytic processing of the precursor, and not by
directly affecting the PPA–a-AI1 inhibition process. As for
the two other residues proposed as the active-site-binding
residues (Trp188 and Tyr190), it is clear that Trp188(I)
does not make any interaction with the catalytic residues,
but as noted above, it is involved in stacking features with
enzyme residues lining the entrance of the binding cleft.
Further along the strand, the sidechain of residue Tyr190(I)
forms strong contacts with the catalytic residue Asp300 (E)
and is involved in hydrophobic contacts with the flexible
loop (Table 1). These interactions constitute a possible
explanation for the results of Mirkov et al. that showed that
these residues are important for the activity of a-AI1 [22].
The observed structural arrangement suggests that the
processing of the polypeptide at Asn77(I), which is neces-
sary to activate the inhibitor, may induce a conformational
change since the segment 73–74 of the inhibitor structure
and particularly the segment 78–81 at the N terminus of
the b subunit deviate from the corresponding lectin loop;
the latter segment swings outwards, exposing and posi-
tioning residues that can then interact with the enzyme
(Table 1; Fig. 3a). It appears that the uncleaved loop (as
seen in the corresponding LoLI structure) would overlap
with the sidechain of the inhibitor residue, Trp188. This
might be related to earlier proposals suggesting that the
polypeptide cleavage removes a conformational constraint
on the precursor to produce the biochemically active
molecule [13].
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Figure 5
Hydrophobic stacking features in the active-
site depression. Thick lines correspond to the
amino acid residues from the enzyme. The
density is from a 2Fo–Fc SIGMAA-weighted
[31] map contoured at 1s. 
Comparison with the acarbose–PPA interaction
The X-ray crystal structures of the PPA–acarbose com-
plexes [3,17] provide details of the relative disposition of
atoms in the enzyme–carbohydrate-inhibitor interaction.
They represent a subset of residues directly involved in
binding the inhibitor and/or in a position to assist catalysis.
In the catalytic center, the carboxylic oxygens of the cat-
alytically competent residues Glu233 and Asp300 form
hydrogen bonds with the ‘glycosidic’ NH group of the
acarviosine moiety, and Asp197 lies on the opposite side 
of the inhibitor-binding cleft. After considering these crys-
tallographic results, we proposed that both Asp197 and
Glu233 are required to produce the b-linked glycosyl-
enzyme intermediate. Recent results [21] clearly confirm
the role of Asp197 as the catalytic nucleophile; Glu233 and
Asp300 are hydrogen bonded to each other via an inter-
vening water (W555) as well as to the glycosidic amine [3],
and may be involved in acid/base catalysis.
The information derived from this structure, the structure
of PPA in complex with the proteinaceous inhibitor a-
AI1, is therefore strikingly different around the active-site
cleft from that derived from previous a-amylase–inhibitor
complexes.
The current structural analysis clearly shows intimate 
contacts between the bean inhibitor and the a-amylase
catalytic residues (Figs 3b,6). The analysis of the present
structure discloses that elements from the inhibitor mol-
ecule manage to fill the whole substrate-docking region of
PPA producing interactions similar to the enzyme–carbo-
hydrate-based-ligand interactions. These elements occupy
the ligand-induced functional position of the enzyme
residues required for binding and/or catalysis (Fig. 7).
The segments of b strands from the two inhibitor loops 
L1 and L2 follow the track of the flexible loop that form 
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Figure 6
Schematic representation of the network of
interactions within the catalytic center. The
enzyme chloride ion is shown in interaction
with some of its ligands (Arg195, Asn298 and
H20). The calcium ion of the enzyme structure
(liganded to Asn100 and His201) and the
presumed calcium ion of the inhibitor
structure are involved in the interaction.










































































the surface edge of the active site upon acarbose-ligand
binding. Sidechains of residues from the strands run into
the cleft and mimic the interactions between the sugar
ligand and enzyme. In the present structure, Gln187(I)
stacks against the indole ring of Trp59(E) as observed for
the carbohydrate inhibitor’s surface in subsite 1 and 2 [3]. A
similar mimicry is produced by the hydrophobic sidechains
of residues Trp188(I) and Phe105(I) stacking against the
sidechains of residues Leu162(E) and Val163(E) (Fig. 5),
which are known to stack against the acarbose surface in
subsite 4. As noted above, these regions of the enzyme
molecule also appear to mediate the hydrophobic contacts
with the binding segments of inhibitor Tendamistat [4].
Residue Asp38(I) on the loop L1 completely occupies the
subsite 5 and blocks the access to the region of the ligand-
reducing end. Residue Try190 occupies the position of
His305(E) in its functional position bound to the carbohy-
drate ligand (Fig. 7).
At the heart of the substrate-binding site, two tyrosine
residues Tyr37(I) and Tyr186(I) (Fig. 3a,b), protruding
from the extremity of the two hairpin loops L1 and L2 
of a-AI1 combine to provide interactions with the pre-
sumed catalytic residues of the enzyme, Glu233(E) and
Asp197(E), respectively. These interactions mimic those
made by the carbohydrate ligand and structural water mol-
ecules observed in the catalytic center [3]. This structural
arrangement shows that the proteinaceous inhibitor a-AI1
targets the catalytic nucleophile [21] and its probable part-
ners in the catalytic event.
The hydroxyl group of Tyr37(I) makes a strong hydrogen
bond with Oε1 of Glu233(E), the most appropriate candi-
date for the role of the general acid in the first stage of
the catalytic process. This tyrosine group strictly replace
the water molecule (W555), present close to the point 
of the catalytic attack (Fig. 7), and makes an identical
hydrogen-bonding pattern [3] with Glu233(E) and the
chloride ligand Asn298(E) (Figs 3b,6). The hydrogen
bond with Od1 of Asp300 is lost because, in the present
complex, the aspartic acid sidechain does not rotate to
adopt its functional position. Asp300 retains the confor-
mation observed in the free enzyme and is stabilized by
hydrogen bonds to the hydroxyl group of Ser189(I) and 
to two water molecules and a presumed Ca2+ ion accom-
panying the inhibitor. The aspartic acid sidechain sticks
out into the catalytic center between the nearly parallel
aromatic side-chains of Tyr37(I) and Tyr190(I).
Moving along the second inhibitor hairpin loop (L2) of
a-AI1, Tyr186(I) is strongly hydrogen bonded to Od1 of
the catalytic nucleophile Asp197(E) [21], which is located
on the opposite side of the substrate binding cleft. The
phenol ring of the inhibitor residue sidechain is roughly
parallel to the partly planar cyclitol ring of the acarviosine
moiety (Fig. 7) and its hydroxyl group mimics the O-6
oxygen atom of the cyclitol ring in the PPA–acarbose
complex [3]. It is noteworthy that in the crystal structure
the residue Tyr186(I) displays a conformation which falls
significantly outside the energetically preferred regions of
the Ramachandran diagram ([24]; Fig. 8). It is maintained
in this position by the interactions described here above.
In addition, its mainchain carbonyl and amine groups form
hydrogen bonds with the hydroxyl group of Ser189(I),
which in turn is hydrogen bonded to the carboxylic
oxygen of Asp300(E).
Solvent structure
In the PPA–a-AI1 complex, most of the water molecules of
the solvent network that occupy the active-site cleft in the
free state of PPA are replaced by the two tyrosine residues
Tyr37(I) and Tyr186(I). Only three ordered solvent mol-
ecules present in the free enzyme (W587, W643 and
W748) keep their position [2] in the very central part of the
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Figure 7
Substrate mimicry. Stereoview of the
superimposition of a-AI1 peptide groups on
the acarbose ligand (coloured pink) and
‘flexible loop’ (coloured blue) from the
PPA–acarbose complex [3]. The loop L1
(coloured yellow) of a-AI1 mimics the closed
position of the enzyme-flexible loop (blue) in
the region that accommodates the reducing-
end glucose (subsite 5). The part of the
flexible loop involved in the architecture of the
non-reducing end (subsites 2 and 1) is
mimicked by the inhibitor segment from loop
L2, coloured green. Also shown in blue are
the catalytic residues Glu233(E) and
Asp197(E), which interact with the inhibitor
residues Tyr186 and Tyr37. Water molecule
W555 (blue sphere; from the free and
acarbose-complexed PPA structures)
superimposes with the hydroxyl group of
Tyr37(I). The yellow sphere corresponds to a
water molecule W643 from the PPA–a-AI1
complex (see text).
catalytic cavity, between Glu233, Asp197 and Arg195. Of
these, W643 appears to be the most firmly bound to the
three residues (Fig. 3b). In PPA, structural water molecules
W555 and W635 constitute a solvent channel that bridges
across the cleft from carboxyl groups of Glu233 and Asp300
to the amide group of Asn298 (the Cl ion ligand) and the
flexible loop [2,3]. In the PPA–a-AI1 complex channel this
is replaced by the sidechain of Tyr37(I). As mentioned
above, W555 is strictly replaced by the hydroxyl group of
Tyr37(I), and W635 is replaced by a ring atom. On the
other slope of the active-site depression, the part of the
solvent channel found in the free enzyme that leads to
bulk solvent [2] is replaced by the sidechain of Tyr186(I):
its hydroxyl group substitutes W566 which was hydrogen-
bonded with Od1 of Asp197 and the next three water 
molecules of the network are replaced by the tyrosine
sidechain. Thus in the PPA–a-AI1 complex the central
region is completely protected from the bulk solvent. The
water molecule, W643, observed in both the free [2] and a-
AI1-complexed PPA, is exchanged with the solvent in the
PPA-acarbose complex, while W555 is close to the place 
of the catalytic attack [3]. In the PPA–a-AI1 complex, we
observed a reversed situation, since W643 remains strongly
bound to the catalytic residues while W555 is cancelled by
the ligand. In the PPA–acarbose complex the catalytic
center is occupied by the pseudo-disaccharide acarviosine,
which is the essential structural unit responsible for the
activity of all inhibitors of the acarbose type. The acarbose
inhibitor (Fig. 7) gets deeper in the cleft and pushes the
water molecule 643 out. W555, which was previously pro-
posed to be the attacking nucleophile able to move to 
the ideal position for the nucleophilic attack at C1 [25], is
conserved in all known a-amylase structures.
The structural analysis of the PPA–a-AI1 complex shows
that all the important elements of the catalytic process are
involved in the interaction between the enzyme and the
proteinaceous inhibitor.
We have thus shown that a-AI1 inactivates PPA through
an elaborate blockage of the substrate binding site on the
enzyme. The stability of the complex results from an
extensive set of interactions between the inhibitor and 
the enzyme. In particular, the inhibitor makes substrate
‘mimetic’ interactions with the binding subsites on the
enzyme and all the catalytically competent elements of
the enzyme are targeted. The hairpin loops L1 and L2
form several favourable interactions to residues that are
highly conserved in the active site of a-amylases. Thus,
the hairpins could serve as a template with which to
design peptide-analog inhibitors. The knowledge of this
inhibition mechanism is of predominant interest from the
medical point of view (diabetes) and for crop protection
(via plant genetic engineering).
Biological implications
Carbohydrate normally represents the majority of the
human diet, and starch accounts for the major part of
the ‘carbohydrate pool’. Enzymatic degradation of poly-
saccharides is of particular significance in carbohydrate
assimilation; cleavage of starch by a-amylases consti-
tutes the first step of the process. The knowledge of the
inhibition mechanism of a-amylases is of predominant
interest from a medical point of view. For example,
inhibition of glycolytic enzymes, especially a-amylases,
reduces post-prandial glucose peaks, which is of partic-
ular importance in patients with diabetes.
Here we report the structure of a porcine pancreatic
a-amylase (PPA) in complex with the bean Phaseolus
vulgaris inhibitor (a-AI1). This protein inhibits the activ-
ity of both insect and mammalian a-amylases. Its occur-
rence in seeds may explain the resistance of common
bean against bruchid larvae. In addition to the general
interest in inhibition of glycolytic enzymes, understand-
ing the mode of action of these proteins at the molecular
level may provide an insight into the design of transgenic
plants expressing either native or modified a-AI genes
that would be resistant against some predatory insects. 
Determination of the structure of the PPA–a-AI1
complex discloses that elements from the inhibitor mol-
ecule manage to fill the whole substrate-docking region
of the PPA. They mimic the enzyme–acarbose-ligand
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Figure 8
Ramachandran plot of the PPA–a-AI1 complex. (Produced with the
program PROCHECK [33].) Glycine residues are shown as triangles
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interactions and ligand-induced functional position of
enzyme residues required for binding and/or catalysis.
The catalytic nucleophile Asp197 and its probable part-
ners located in the catalytic heart are strongly hydrogen
bonded to inhibitor residues. The results show that inhi-
bition prevents residue Asp300 from adopting its func-
tional position and destroys the water channel leading
from the ‘flexible loop’ to the heart of the active-site
depression. This work shows how mammalian a-amy-
lases and a-amylase inhibitors (carbohydrate-based and
proteinaceous) recognize each other and how the a-amy-
lases are inhibited.
Materials and methods
The structure of the PPA–a-AI1 complex was first solved at medium
resolution (2.9 Å); crystallization, data collection and molecular replace-
ment were performed as described in our previous report [14]. The
crystals belong to the monoclinic space group C2, with a = 151.6 Å,
b = 79.4 Å, c = 68 Å, b = 91.54° and half a complex (one inhibitor
monomer and one enzyme molecule) per asymmetric unit.
Crystallization and data collection
To increase the resolution of the structure determination, new crystal-
lization trials were carried out. The quality of the previously described
crystals was improved by adding 1.8 % n-octyl-b-D-glucopyranoside in
the crystallization drop, a crystallisation reagent frequently utilized to
optimize the crystal growth of macromolecules [26] (the detergent mol-
ecule is not observed in the complex structure). We obtained larger
crystals (size: 0.8 × 0.5 × 0.2 mm, instead of 0.2 × 0.2 × 0.2 mm) diffract-
ing to 1.7 Å resolution. They belong to the same space group and have
identical unit cell dimensions. 
Data were collected at ambient temperature from a single PPA–a-AI1
complex crystal and recorded on a 18cm Mar-Research imaging plate
scanner developed by Hendrix and Lentfer (Hamburg) on beamline X11
(l = 0.928 Å) at the EMBL Hamburg outstation. 95 frames (1° oscillation
steps) were first collected between 9.0 and 1.85Å resolution, low reso-
lution data were taken afterwards through 38 frames (2.5° oscillation
steps) collected from the same crystal, in the same orientation in the
resolution range 35–4.0Å. Data were 96.7% complete from 35–1.85Å
resolution, (Unique reflections: 66769) and 98.4 % complete from
1.92–1.85; the average overall and final shell I/s values are 14.8 and
2.0, respectively. The merging R on intensities Σi (Σj|Ii,j - < Ii>|) / Σi< Ii>
was 5 % (25 % in the last shell). Data sets were processed with the
programs DENZO and SCALEPACK [27].
Structure determination and refinement
The structure was solved by molecular replacement [14] using the
program suite AMoRe [28]. The search models were the refined 2.1Å
resolution structure of PPA [2] and one monomer of the 1.9Å resolu-
tion model of LoLI [15]. The low-resolution structure was refined to a
conventional R factor of 17.6 and a Rfree factor [29] of 29.2 in the range
8.0–2.9 Å. The overall structure of the complex was very well defined,
the interactions were clearly observed in the complex structure as were
two N-glycosylation sites and 131 water molecules. The subsequent
rounds of refinement used the new sets of data and the resolution was
increased to 1.85 Å.
The refinement was based on 66557 independent reflections in the
8.0–1.85Å resolution range and performed by simulated annealing using
X-PLOR [30], followed by manual fitting into SIGMAA-weighting [31]
electron-density maps with the graphics program TURBO-FRODO [32].
The procedure provided very well defined electron density for the enzyme
and the inhibitor, representative (2Fobs–Fcalc) exp(iacalc) electron density
corresponding to the interface of the inhibitor in the active-site region 
of PPA enzyme is shown in Figure 5. However some external turns in the
inhibitor structure (residues 75–77; 90–95; 114–116 and 165–172)
had poor or broken density. The last 19 residues at the C terminus are
not seen in the electron density. The electron density enabled us to iden-
tify a third N-glycosylation site (five potential glycosylation sites are pro-
posed in the literature [16]). All solvent molecules with densities below
1s in the (2Fobs–Fcalc) exp(iacalc) map and temperature factors above
70Å2 were removed after the first iteration of refinement. The difference
electron-density maps revealed additional water molecules. These new
sites were added to the model provided that the electron density was
present at a level of at least 3.5σ in the (Fobs–Fcalc) exp(iacalc) maps. The
molecules introduced were inspected visually for correct geometry of
hydrogen-bonding and were given an initial B factor of 20Å2.
In the course of analyzing the water structure, we discovered two well
ordered water molecules which were in contact with six and five
ligands respectively. This stereochemistry was indicative of calcium
ions; the ligands may be described as lying at the vertices of tetragonal
and trigonal bipyramids respectively, ~2.4 Å from the ion in the center.
In addition, a water molecule was not sufficient to account for the
observed density. We therefore introduced two calcium ions, which
appeared consistent with the subsequent refinement procedure; their
rather high B values (~40 Å2) suggest partial occupancy of the sites,
however. The B factors of the surrounding protein atoms have similar
values for ligands of the presumed ion located at the enzyme–inhibitor
interface, lower values (~14 Å2) are observed for ligands from the
inhibitor active site. So far, no metal ion has been identified in the bean
inhibitor molecule and the unequivocal identification of the bound metal
ions requires separate analysis. 325 water molecules were built into
the electron density.
Quality of the final model
The final refined model yielded a conventional crystallographic R factor of
18.3% including all data from 8.0–1.85 Å and a Rfree of 22% (the Rfree
factor was monitored separately, throughout similar refinement stages
with a test set of 10% of the data). The quality of the refined structure
was assessed using PROCHECK [33]. Figure 8 illustrates a Ramachan-
dran plot [24] of the F/Ψ angles. All residues (except two, see below) are
in allowed regions; 90.1% of the amino acid residues are in the most
favoured region, only two residues (Ser114(E) [17] and Asp186(I) which
are well defined in the density) are in the generously allowed region.
Residue Asp186(I) is strongly hydrogen bonded to the catalytic residue
Asp197(E) of the enzyme. The model has good stereochemistry (rms
deviations on bond lengths, 0.010Å; bond angles, 1.48°; and planar
groups 0.03Å). The upper estimate of the error in the atomic positions
from the Luzzati plots [34] using the free R factor and a SIGMAA-plot
[31] is 0.2Å. The final model involving one enzyme molecule and the
monomer unit of the inhibitor consists of 5448 protein atoms (i.e., all non-
hydrogen atoms), 70 carbohydrate atoms (inhibitor N-glycosylation moi-
eties), 325 water molecules, one Cl– ion (E) and one Ca2+ ion (E), and
two presumed Ca2+ ions (I). The average B factor is 23.65Å2 for protein
atoms, (20.84Å2 and 24.76Å2 for mainchain and sidechain atoms,
respectively); 45.77Å2 for sugar atoms and 31.47Å2 for solvent atoms.
Accession numbers
The atomic coordinates have been deposited at the Brookhaven Protein
Data Bank (entry code 1DHK).
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